Impact of stromal maturity and proportion on prognosis and immune landscape in colorectal cancer
Tapiainen, Vilja V.; Sirniö, Päivi; Karjalainen, Henna; Äijälä, Ville K.; Kastinen, Meeri; Pohjanen, Vesa Matti; Elomaa, Hanna; Sirkiä, Onni; Ahtiainen, Maarit; Helminen, Olli; Wirta, Erkki Ville; Lindgren, Outi; Mattila, Taneli T.; Rintala, Jukka; Meriläinen, Sanna; Saarnio, Juha; Rautio, Tero; Seppälä, Toni T.; Böhm, Jan; Mecklin, Jukka Pekka; Tuomisto, Anne; Mäkinen, Markus J.; Väyrynen, Juha P. (2025-12)
Tapiainen, Vilja V.
Sirniö, Päivi
Karjalainen, Henna
Äijälä, Ville K.
Kastinen, Meeri
Pohjanen, Vesa Matti
Elomaa, Hanna
Sirkiä, Onni
Ahtiainen, Maarit
Helminen, Olli
Wirta, Erkki Ville
Lindgren, Outi
Mattila, Taneli T.
Rintala, Jukka
Meriläinen, Sanna
Saarnio, Juha
Rautio, Tero
Seppälä, Toni T.
Böhm, Jan
Mecklin, Jukka Pekka
Tuomisto, Anne
Mäkinen, Markus J.
Väyrynen, Juha P.
12 / 2025
Annals of Medicine
2606512
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202601121309
https://urn.fi/URN:NBN:fi:tuni-202601121309
Kuvaus
Peer reviewed
Tiivistelmä
Background: Tumour microenvironment and cancer cells have constant interaction affecting cancer progression. Tumour-stroma ratio (TSR) in the tumour centre and desmoplastic reaction (DR) classification at the invasive margin are prognostic factors based on stroma evaluation on H&E slides. However, their combined value and immunological associations remain poorly defined. This study examines the prognostic and immunological value of TSR, DR, and their combination in two large colorectal cancer cohorts. Methods: Two colorectal cancer cohorts (N = 1,876) were analyzed. We introduced a three-tiered Stromal Maturity and Proportion Score (SMAPS) based on the presence of high (>50%) TSR and myxoid stroma (immature DR classification). Alcian blue staining was used to further quantify myxoid stroma. Multiplex immunohistochemistry combined with digital image analyses, was utilized to study immune cell densities associated with SMAPS, TSR, DR, and Alcian blue intensity. Results: In the study cohort (N = 1,100), SMAPS was a stronger predictor of cancer-specific mortality [HR for high (vs. low) SMAPS 2.01 (95% CI 1.47–2.75), p < 0.0001] compared to TSR [HR for stroma-high (vs. stroma-low) 1.49 (95% CI 1.15–1.93), p = 0.003] and DR classification [HR for immature (vs. mature) 1.84 (95% CI 1.39–2.45), p < 0.0001]. High SMAPS, stroma-high TSR, and immature DR correlated with lower densities of CD3+ T cells, B cells, M1-like macrophages, CD66B+ granulocytes, and mast cells. Alcian blue staining was associated with immature DR and corresponding immune cells. The validation cohort (N = 776) confirmed the association of SMAPS with survival and T cell densities. Conclusions: TSR and DR are independent prognostic factors for cancer-specific survival. SMAPS is a promising prognostic tool that integrates stromal maturity at the invasive margin and stromal proportion in the tumour centre. SMAPS has stronger prognostic value compared to TSR and DR classifications alone. A high stromal proportion and myxoid content are associated with an immunosuppressive microenvironment characterized by lower densities of antitumourigenic immune cells.
Kokoelmat
- TUNICRIS-julkaisut [24199]
